Schedule 13G ownership disclosure
GALMED PHARMACEUTICALS LTD
Security class unavailable · CUSIP: M47238106
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 778,965
- Percent of class
- 3.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-008145
- Form type
- SC 13G
- Filer
- Galmed Pharmaceuticals Ltd.
- CIK
- CIK 1595353
- Filed
- Feb 14, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership